Winton Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,071
Closed -$819K 1031
2023
Q1
$819K Buy
13,071
+3,247
+33% +$203K 0.05% 510
2022
Q4
$615K Buy
9,824
+543
+6% +$31.1K 0.04% 571
2022
Q3
$462K Buy
+9,281
New +$514K 0.03% 665
2021
Q3
Sell
-19,051
Closed -$993K 1446
2021
Q2
$993K Buy
19,051
+3,635
+24% +$175K 0.05% 528
2021
Q1
$680K Sell
15,416
-1,357
-8% -$57K 0.04% 704
2020
Q4
$585K Sell
16,773
-13,086
-44% -$465K 0.04% 706
2020
Q3
$1.09M Buy
29,859
+14,930
+100% +$555K 0.04% 788
2020
Q2
$561K Buy
+14,929
New +$597K 0.01% 1162

Other funds holding PBH

Winton Group's PBH Position: Q2 2023 in Review

Winton Group sold out of Prestige Consumer Healthcare (PBH) in Q2 2023, closing a stake of 13,071 shares — an estimated $819K sold.

Winton Group first reported a position in PBH in Q2 2020 and held it in 8 quarters. The position peaked at $1.09M in Q3 2020. 279 funds tracked by Wall St. Rank hold PBH as of Q2 2023.

  • Winton Group reported no remaining Prestige Consumer Healthcare position as of Q2 2023 after selling out during the quarter.
  • Winton Group sold 13,071 Prestige Consumer Healthcare shares in Q2 2023, an estimated $819K.
  • Winton Group first reported a position in Prestige Consumer Healthcare in Q2 2020 and held it in 8 quarters.
  • Winton Group's Prestige Consumer Healthcare position peaked at $1.09M in Q3 2020.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2023.

Based on Winton Group's 13F filing for Q2 2023, filed 14 Aug 2023.